The Home of the Life Sciences Industry

Pictured: Biogen's building in Massachusetts/iStoc

Biogen Beats Q1 Profit Estimates as Leqembi Sales Start to Take Off

Biogen on Wednesday exceeded analyst profit estimates for the first quarter of 2024 as the biotech’s cost-cutting measures took hold and sales of its Alzheimer’s disease therapy Leqembi started to pick up.
Pictured: Roche's building in Shanghai, China/iSto

Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds

Despite being hit with a continuing decline in COVID-19 sales and a strong Swiss franc, Roche on Wednesday reported first-quarter sales were up 2% at constant exchange rates.